NCT07509190 Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes
| NCT ID | NCT07509190 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anny Reyes |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 310 participants |
| Start Date | 2026-03-18 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 310 participants in total. It began in 2026-03-18 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes. For the first part, patients (age 18+) and providers will be asked to complete surveys and participate in focus groups to identify gaps and barriers that limit access to and use of epilepsy surgery. For piloting the education program, patients (age 18+) at the Cleveland Clinic Epilepsy Monitoring Unit will be randomized to intervention or control. Those in the intervention group, in addition to their usual care, will also receive educational materials on social determinants of health and their influence on surgical rates and epilepsy outcomes. Those in the control group will receive their usual care. Both groups will be asked to fill out surveys and questionnaires at the beginning of their stay, at the end of their stay, and if they elect to have surgery, 12 months after surgery.
Eligibility Criteria
Inclusion Criteria: * Part 1: * Epilepsy diagnosis * Completion of epilepsy surgical evaluation at Cleveland Clinic * Recommendation for resective/ablation surgery or implantation of neurostimulation device * At least 18 years old * Part 2a - Patient survey: * At least 18 years old * Epilepsy diagnosis * Evaluated for epilepsy surgery * English proficiency enough to complete survey * Part 2a - Provider survey: * Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy * Part 2b - Cleveland Clinic patient focus groups: * Epilepsy diagnosis * Previously completed epilepsy workup at Cleveland Clinic * At least 18 years old * Has Basic Interpersonal Fluency Skills in English (based on phone interview) * Has no evidence of dementia or intellectual disability that would interfere with participation in the focus group * Part 2b - Cleveland Clinic provider focus groups: * Clinicians that are members of Cleveland Clinic Epilepsy Center and provide care to patients with epilepsy * Part 2b - Community patient focus groups: * Epilepsy diagnosis * Previously completed epilepsy workup * At least 18 years old * Has Basic Interpersonal Fluency Skills in English (based on phone interview) * Part 2b - Community provider focus groups: * Clinician that provides care to patients with epilepsy outside of Cleveland Clinic * Part 3: * At least 18 years old * Fluent in English * Being evaluated for epilepsy surgery at the Cleveland Clinic Epilepsy Monitoring Unit Exclusion Criteria: * Part 1: * Previous epilepsy surgery or implantation of neurostimulation device * Part 2a - Patient survey: * Unable to fluently read English * Has evidence of dementia or intellectual disability that would interfere with patient's understanding of surveys * Part 2a - Provider survey: * Unable to fluently read English * Part 2b - Cleveland Clinic patient focus groups: * Is not fluent in English * Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group * Has had prior epilepsy surgery * Part 2b - Cleveland Clinic provider focus groups: * Clinicians involved in the development of the study design * Part 2b - Community patient focus groups: * Is not fluent in English * Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group * Has had prior epilepsy surgery * Part 3: * Is not fluent in English * Evidence of dementia or intellectual disability that would interfere with patient's understanding of intervention
Contact & Investigator
Anny Reyes, PhD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT07509190 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07509190 currently recruiting?
Yes, NCT07509190 is actively recruiting participants. Contact the research team at REYESA14@ccf.org for enrollment information.
Where is the NCT07509190 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07509190 clinical trial?
NCT07509190 is sponsored by Anny Reyes. The principal investigator is Anny Reyes, PhD at The Cleveland Clinic. The trial plans to enroll 310 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.